REGISTER FOR TOUCH BRIEFINGS |
|
|
|
Register for touch briefings
|
|
|
|
|
|
|
|
Touch Briefings welcomes editorial submissions for inclusion within our print reports and website from industry practitioners.
|
|
|
|
|
|
US ONCOLOGICAL DISEASE 2006 - ISSUE II - DECEMBER 2006 |
|
Contents:
Contents
Advisory Panel
Foreword
|
Foreword
Professor John Smyth President, Federation of European Cancer Organisation
|
Breast Cancer
|
|
The Risk of Early Recurrence and Distant Metastases
Hope S Rugo, MD
Clinical Professor of Medicine, Director, Breast Oncology Clinical Trials Program, University of California
San Francisco Comprehensive Cancer Center
|
|
|
Reducing the Risk of Late Relapse in Postmenopausal Women with Hormone-sensitive Breast Cancer—Extended Adjuvant Letrozole
Melinda Wu1 and Paul E Goss, MD, PhD2
1. Research Assistant, University of Toronto, and
2. Professor of Medicine, Harvard Medical School and Director of Breast Cancer Program, Massachusetts General Hospital Cancer Center
|
|
|
Role of Radiotherapy in Patients with Early Breast Cancer
M Houman Fekrazad, MD,1 Anne Marie Wallace, MD,1 Claire Verschraegen, MD,1 Vincent Vinh-Hung, MD,PhD,2 Eva Zavadova1 and Melanie Royce1
1. Cancer Research and Treatment Center, University of New Mexico,
2. The Oncology Center at the Academic Hospital, VUB Free University, Brussels, Begium
|
Lung Cancer
|
|
Cytoreductive Surgery Combined with Perioperative Intraperitoneal Chemotherapy for Diffuse Malignancy Peritoneal Mesothelioma
Paul H Sugarbaker, MD, FACS, FRCS and Tristan D Yan, BSc (Med), MBBS
Program in Peritoneal Surface Oncology, Washington Cancer Institute, Washington Hospital Center
|
|
|
Novel Agents in the Treatment of Lung Cancer
Nikhil I Khushalani, MB, BS and Alex A Adjei, MD, PhD Roswell Park Cancer Institute
|
Malignant Mesthelioma
|
|
Managing Resistance to Gastrointestinal Stromal Tumors
Jean-Yves Blay, MD, PhD,1,3 Philippe Cassier,1 Armelle Dufresne,1 Jerome Fayette,1 Pierre Paul Bringuier,1 Isabelle Ray-Coquard,2 Laurent Alberti,2 and Severine Tabone-Eglinger2
1. Hôpital Eduord Herriot, Unité d’Oncologie Médicale,
2. INSERUM U590 Centre Léon Bérard, and
3. Départment de Médicine, de Chirurgie et d’Anatomopathologie, Centre Léon Bérard
|
|
|
Long-term Disease Control with Imatinib Treatment in Metastatic Gastrointestinal Stromal Tumors
Margaret von Mehren, MD Director of Sarcoma Oncology, Member of the Department of Medical Oncology, Fox Chase Cancer Center
|
|
|
Imatinib Efficacy in Gastrointestinal Stromal Tumors
Heikki Joensuu, MD Department of Oncology, Helsinki University Central Hospital
|
|
|
Early Gastrointestinal Stromal Tumor Resection and Adjuvant Therapy with Imatinib
Peter Hohenberger Director of Surgery, Department of Surgery, Division of Surgical Oncology and Thoracic Surgery, Faculty of Clinical Medicine Mannheim, University of Heidelberg, Heidelberg, Germany
|
Gastric Cancer
|
|
New Treatments for Advanced Gastric Cancer
David Cunningham, MD, FCRP,1 and Naureen Starling, BSc (Hons), MRCP2
1.Head of the Gastrointestinal and Lymphoma Units, Royal Marsden Hospital, and
2.Clinical Research Fellow
|
Gynecological Cancer
|
|
Novel Management Strategies for Female Pelvic Cancers
Maurie Markman, MD
Vice President for Clinical Research, Department of Gynecologic Medical Oncology,
University of Texas MD Anderson Cancer Center
|
|
|
Treatment of Advanced Epithelial Ovarian Cancer
Joyce Liu, MD1 and Ursula Matulonis, MD2
1. Clinical Fellow, Adult Oncology,
2. Director, Medical Gynecologic Oncology, Department of Oncology, Dana Farber Cancer Institute
|
Genito-Urinary Oncology
|
|
Current Management of Bladder Cancer
Matthew D Galsky, MD, Guru Sonpavde, MD and
Thomas E Hutson, DO, PharmD
Genitourinary Oncology Program, US Oncology Research Network
|
Myelodysplastic Syndromes
|
|
Removing the Burden—Iron Overload and Deferasirox (ICL670)
Maria Domenica Cappellini, MD Internal Medicine Department and Department of Emergency Medicine, University of Milan
|
|
|
Iron Overload—Screening and Diagnosis
Fahd Quddus, MD,1 Naomi Galili, PhD2 and Azra Raza, MD2
1. Radhey Khanna MDS Center,
2. Division of Hematology, University of Massachusetts
|
Radiotherapy & Imaging
|
|
Fiducial Markers in Image-guided Radiotherapy of the Prostate
Clifton David Fuller, MD, and Todd J Scarbrough, MD Department of Radiatioin Oncology, University of Texas and Professor of Radiation Medicine, Oregon Health & Science University
|
|
|
Compensator-intensity-modulated Radiotherapy—A Traditional Tool for Modern Application
Sha Chang Associate Professor and Chief of Physics & Computing, Department of Radiation Oncology, University of North Carolina Medical School
|
|
|
Adjuvant Radiation Therapy for Locally Advanced Bladder Cancer
Mohamed Saad Zaghloul, MD Radiation Oncology Department, National Cancer Institute, Cairo University
|
Cancer Diagnostics
|
|
Nanotechnology in Personalized and Predictive Oncology
May D Wang, PhD, Jonathan W Simons, MD, and Shuming Nie, PhD Georgia Institute of Technology and Emory University School of Medicine
|
Metastic Bone Cancer
|
|
The International Society of Geriatric Oncology Task Force on Bisphosphonates in Elderly Patients
Jean-Jacques Body1 and Matti Aapro2
1. Université Libre de Bruxelles, Institut Jules Bordet and CHU Brugmann, and
2. Clinique de Genolier
|
Cancer Pain
|
|
Management of Breakthrough Pain in the Cancer Patient
Chris Pasero, MS, RN,C, FAAN Pain Management Educator and Clinical Consultant
|
|
|
Pharmaceutical Management of Cancer Breakthrough Pain
Lynn R Webster, MD, FACPM, FASAM Medical Director, Lifetree Clinical Research and Pain Clinic
|
Cancer-related Nutrition
|
|
Long-term Enteral Nutrition Facilitates Optimization of Body Weight
Mark A Schattner, Holly J Willis, Alexandra Raykher, Patricia Brown, Ofelia Quesada, Burma Scott and Moshe Shike Department of Medicine, Memorial Sloan-Kettering Cancer Center
|
|
|
Cancer and Nutrition—The Importance of Preventing Weight Loss Throughout the Treatment Continuum
James T D’Olimpio, MD Director of Supportive/Palliative Oncology and the Cancer Pain and Symptom Control Service, North Shore University Hospital
|
Reference Section
|
|
Fiducial Markers in Image-guided Radiotherapy of the Prostate
Clifton David Fuller, MD, and Todd J Scarbrough, MD Department of Radiation Oncology, University of Texas and Professor of Radiation Medicine, Oregon Health & Science University
|
|
|
Current Management of Bladder Cancer
Matthew D Galsky, MD, Guru Sonpavde, MD and Thomas E Hutson, DO, PharmD Genitourinary Oncology Program, US Oncology Research Network
|
|
|
Cytoreductive Surgery Combined with Perioperative Intraperitoneal Chemotherapy for Diffuse Malignancy Peritoneal Mesothelioma
Paul H Sugarbaker, MD, FACS, FRCS and Tristan D Yan, BSc (Med), MBBS Program in Peritoneal Surface Oncology, Washington Cancer Institute, Washington Hospital Center
|
|
|
Adjuvant Radiation Therapy for Locally Advanced Bladder Cancer
Mohamed Saad Zaghloul, MD Radiation Oncology Department, National Cancer Institute, Cairo University
|
Technology & Services Section
|
|
Corporate Report
Nestlé Nutrition
|
|
|
|
|
|
